Título original
Lipoprotein (a), Measured with an Assay Independent of Apolipoprotein(a) Isoform Size, and Risk of Future Cardiovascular Events among Initially Healthy Women

Título en castellano
Lipoproteína (a). Medida con un Ensayo Independiente del Tamaño de la Isoforma de la Apolipoproteína (a) y Riesgo de Futuros Eventos Cardiovasculares en Mujeres Inicialmente Sanas

Palabras clave
lipoproteína (a), riesgo cardiovascular, mujeres sanas, estudio prospectivo

Key Words
lipoprotein (a), cardiovascular risk, healthy women, prospective study

Autores
Suk Danik J, Rifai N, Buring JE, Ridker PM

Dirigir correspondencia a:
J Suk Danik, Donald W. Reynolds Center for Cardiovascular Research The Leducq Foundation Center for Vascular Research, MA 02215, Boston, Massachusetts, EE.UU.

Patrocinio
Donald W Reynolds Foundation, Leducq Foundation; National Heart, Lung and Blood Institute; National Cancer Institute.

Conflicto de interés
National Heart, Lung and Blood Institute (Dr a. Suk Danik); Merck Research Laboratories, Sanofi Aventis, Ortho Diagnostics (Dr Rifai); National Institutes of Health, Dow Corning Corporation, Bayer Health Care, Natural Source Vitamin E Association, Procter & Gamble (Dra Buring); National Heart, Lung and Blood Institute, National Cancer Institute, American Heart Association, Doris Duke Charitable Foundation, Leducq Foundation, Donald W Reynolds Foundation, James and Polly Annenberg La Vea Charitable Trust, Astra Zeneca, Bayer, Bristol Myers Squibb, Dade Behring, Novartis, Pharmacia, Roche, Variagenics, Schering Plough, Isis Pharmaceutical, Interleukin Genetics (Dr Ridker).

Institución
Donald W. Reynolds Center for Cardiovascular Research, Boston, EE.UU.